All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
GAIN THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: GANX

Business Address

4800 HAMPDEN LANE
SUITE 200
BETHESDA , MD US 20814

Mailing Address

4800 HAMPDEN LANE
SUITE 200
BETHESDA , MD US 20814
Phone Number: (301) 500-1556 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $11,794,949.00 $4,272,501.00 $6,319,925.00 $5,988,202.00 $7,311,611.00 $10,879,884.00 $14,305,949.00 $34,338,585.00 $36,880,673.00 $40,979,225.00 $43,162,583.00 $46,593,604.00 $7,492,910.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- $24,713.00 $353,166.00 $4,486.00 $8,548.00 -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $741,638.00 $906,834.00 $954,584.00 $1,368,871.00 $848,854.00 $1,552,358.00 $1,456,059.00 $1,932,286.00 $727,785.00 $550,748.00 $808,456.00 $774,809.00 $257,011.00 -- -- --
Total Current Assets $17,778,868.00 $13,241,557.00 $17,308,448.00 $19,321,984.00 $21,091,296.00 $24,349,323.00 $25,833,090.00 $36,392,013.00 $37,722,044.00 $41,554,686.00 $44,335,174.00 $47,384,028.00 $8,987,828.00 -- -- --
Property Plant and Equipement $125,962.00 $127,393.00 $138,556.00 $144,636.00 $144,379.00 $136,717.00 $138,909.00 $106,725.00 $105,986.00 $103,050.00 $75,063.00 $54,717.00 $29,633.00 -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- $59,740.00 $51,665.00 -- -- --
Total Assets $18,609,331.00 $14,097,448.00 $18,260,874.00 $21,322,575.00 $24,099,387.00 $28,325,619.00 $31,890,036.00 $37,598,542.00 $38,985,071.00 $42,562,460.00 $45,353,028.00 $48,041,064.00 $9,604,358.00 -- -- --
Accounts Payable $1,300,000.00 $1,376,859.00 $900,000.00 $2,200,000.00 $1,626,100.00 $1,018,809.00 $948,902.00 $2,118,443.00 $560,479.00 $789,387.00 $978,393.00 $881,753.00 $961,516.00 -- -- --
Accrued Liabilities $1,016,582.00 $1,336,050.00 $1,753,880.00 $1,263,183.00 $1,082,091.00 $2,068,366.00 $1,070,396.00 $656,469.00 $681,770.00 $1,467,253.00 $325,079.00 $764,220.00 $379,270.00 -- -- --
Total Current Liabilities $6,031,107.00 $6,766,681.00 $7,168,040.00 $6,183,745.00 $5,219,873.00 $5,662,858.00 $4,873,381.00 $5,770,751.00 $4,167,525.00 -- -- -- -- -- -- --
Long Term Debt $567,850.00 $544,219.00 $578,274.00 $587,496.00 $603,393.00 $585,283.00 $626,010.00 $647,513.00 $694,294.00 -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $247,241.00 $90,660.00 $134,323.00 $96,310.00 $35,627.00 $-296,900.00 $-145,568.00 $-114,302.00 $-90,645.00 $-112,078.00 $-164,118.00 $-156,861.00 $-152,698.00 -- -- --
Accumulated Deficit $-38,516,197.00 -- -- $-38,516,197.00 $-20,925,459.00 $-20,925,459.00 $-20,925,459.00 $-20,925,459.00 $-7,034,853.00 $-7,034,853.00 $-7,034,853.00 $-7,034,853.00 $-3,457,171.00 -- -- --
Total Stockholders' Equity $12,578,224.00 $7,330,767.00 $11,092,834.00 $15,138,830.00 $18,879,514.00 $22,662,761.00 $27,016,655.00 $31,827,791.00 $34,817,546.00 $37,545,236.00 $41,388,904.00 $44,464,009.00 $6,201,989.00 $-476,591.00 $70,400.00 $-449,856.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $18,609,331.00 $14,097,448.00 $18,260,874.00 $21,322,575.00 $24,099,387.00 $28,325,619.00 $31,890,036.00 $37,598,542.00 $38,985,071.00 $42,562,460.00 $45,353,028.00 $48,041,064.00 $9,604,358.00 -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues $55,180.00 $55,180.00 $55,180.00 $55,180.00 $140,108.00 $140,108.00 $95,102.00 $45,006.00 $164,994.00 $27,345.00 $94,441.00 $5,269.00 -- $13,047.00 $6,673.00 --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $11,520,613.00 $2,367,482.00 $6,779,148.00 $2,791,205.00 $8,377,290.00 $6,103,448.00 $4,138,664.00 $1,556,440.00 $7,164,229.00 $5,691,756.00 $3,215,018.00 $1,421,509.00 -- $856,127.00 $417,259.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $22,308,313.00 $17,901,083.00 $7,731,114.00 $5,284,964.00 $17,917,153.00 $13,355,954.00 $5,271,487.00 $3,333,483.00 $13,991,167.00 $4,663,270.00 $6,075,921.00 $2,472,184.00 -- $1,057,771.00 $518,933.00 --
Loss from Operations $-22,253,133.00 $-17,845,903.00 $-12,960,898.00 $-5,229,784.00 $-17,777,045.00 $-4,750,984.00 $-5,176,385.00 $-3,288,477.00 $-13,826,173.00 $-10,617,404.00 $-5,981,480.00 $-2,466,915.00 -- $-1,044,724.00 $-512,260.00 --
Loss Before Income Taxes $-22,188,245.00 $-4,696,807.00 $-7,661,380.00 $-5,120,591.00 $-17,497,762.00 $-4,554,161.00 $-5,076,274.00 $-3,270,966.00 $-13,886,598.00 $-10,658,421.00 $-6,000,002.00 $-2,446,968.00 -- $-1,121,760.00 $-582,921.00 --
Earnings Per Share Basic $-1.71 $-1.42 $-1.05 $-0.43 $-1.48 $-1.09 $-0.43 $-0.28 $-1.37 $-1.11 $-0.71 -- -- $-0.57 -- --
Weighted Average Shares Basic 13,011,361 12,701,401 12,387,089 11,935,081 11,883,368 11,883,368 11,883,368 11,883,368 10,165,404 9,587,189 8,431,410 -- -- 1,981,765 -- --
Earnings Per Share Diluted $-1.71 $-1.42 $-1.05 $-0.43 $-1.48 $-1.09 $-0.43 $-0.28 $-1.37 $-1.11 $-0.71 -- -- $-0.57 -- --
Weighted Average Shares Diluted 13,011,361 12,701,401 12,387,089 11,935,081 11,883,368 11,883,368 11,883,368 11,883,368 10,165,404 11,876,745 8,431,410 -- -- 1,981,765 -- --
Common Stock Shares Authorized 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 -- -- --
Common Stock Shares Outstanding 16,206,680 12,782,861 12,632,327 12,087,142 11,883,368 11,883,368 11,883,368 11,883,368 11,883,368 11,879,743 11,876,460 11,876,460 7,694,642 -- -- --
Common Stock Value $1,621.00 $1,278.00 $1,263.00 $1,209.00 $1,189.00 $1,189.00 $1,189.00 $1,189.00 $1,189.00 $1,188.00 $1,188.00 $1,188.00 $354.00 -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com